News Daily News Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION Todd Neale December 16, 2025
News Daily News Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes Michael O'Riordan August 19, 2024
News Daily News Patients With CKD Remain Underrepresented in Trials of CV Meds Todd Neale March 08, 2024
News Daily News Don’t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue Yael L. Maxwell December 15, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Daily News Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2 Yael L. Maxwell November 03, 2022
News Daily News Comorbidities May Drive PAD Procedural Outcomes in Black Patients L.A. McKeown June 23, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT Michael O'Riordan December 09, 2021
News Daily News Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends Shelley Wood November 01, 2021
News Daily News FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes Yael L. Maxwell July 09, 2021
News Daily News Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD Michael O'Riordan May 11, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Statin Benefits: Yes for CVD but No for Everything Else, Says New Review Michael O'Riordan October 08, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018
News Daily News CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition Michael O'Riordan August 04, 2017